Naloxone in the management of hepatic encephalopathy

Journal of Clinical Pharmacy and Therapeutics

Volumn 35, Issue 3, 2010, Pages 333-341

  Jiang, Q ^a   Jiang, G ^a   Welty, T E ^b   Zheng, M ^c  

^a SICHUAN CANCER HOSPITAL   (China)

^b UNIVERSITY OF KANSAS   (United States)

^c THE FIRST AFFILIATED HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Hepatic encephalopathy; Meta analysis; Naloxone; Randomized controlled trials; Treatment

Indexed keywords

NALOXONE;

ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; DRUG EFFICACY; DRUG INTERMITTENT THERAPY; DRUG SAFETY; DRUG TOLERABILITY; HEPATIC ENCEPHALOPATHY; HUMAN; META ANALYSIS; NAUSEA; RANDOMIZED CONTROLLED TRIAL; TREATMENT RESPONSE; VOMITING;

HEPATIC ENCEPHALOPATHY; HUMANS; INFUSIONS, INTRAVENOUS; NALOXONE; NARCOTIC ANTAGONISTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 77952188537     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2009.01120.x     Document Type: Article

References (36)

1. Gitlin N (1996) Hepatic encephalopathy. In : Zakim D, Boyer TD, eds. Hepatology. a textbook of liver disease, 3rd edn, Vol. 1.
2. Blei AT, Córdoba J, for the Practice Parameters Committee of the American College of Gastroenterology (2001) Hepatic encephalopathy. American Journal of Gastroenterology, 96, 1968 1976.
3. Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT the Members of the Working Party (2002) Hepatic encephalopathy - definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology, 35, 716 721.
4. Basile AS, Jones EA (1997) Ammonia and GABA-ergic neurotransmission: interrelated factors in the pathogenesis of hepatic encephalopathy. Hepatology, 25, 1303 1305.
5. Yurdaydin C, Li Y, Ha JH, Rothman R, Basile AS (1995) Brain and plasma levels of opioid peptides are altered in rats with thioacetamide-induced fulminant hepatic failure: implications for the treatment of hepatic encephalopathy with opioid receptor antagonists. Journal of Pharmacology and Experimental Therapeutics, 273, 185 192.
6. Yurdaydin C, Hiirtnagl H, Steindl P et al. (1990) Increased serotoninergic and noradrenergic activity in hepatic encephalopathy in rats with thioacetamide-induced acute liver failure. Hepatology, 11, 371 378.
7. Cooper JR, Bloom FE, Roth RH (1991). Neuroactive peptides. In : The biochemical basis of neuropharmacology, 6th edn.
8. Thornton JR, Losowsky MS (1988) Opioid peptides and primary biliary cirrhoais. British Medical Journal, 297, 1501 1504.
9. Thornton JR, Losowsky MS (1989) Methionine enkephalin is increased in plasma in acute liver disease and is present in bile and urine. Journal of Hepatology, 8, 53 59.
10. Ozsoylu S, Kocak N (1985) Naloxone in hepatic encephalopathy. American Journal of Diseases of Children, 139, 745 750.
11. Eguchi M (2004) Recent advances in selective opioid receptor agonists and antagonists. Medical Care Research and Review, 24, 182 212.
12. Deng JQ (2005) The clinical curative effect observing of naloxone on cirrhotic patients with hepatic encephalopathy. International Medicine and Health Guidance News, 11, 70 71.
13. Hu QJ, Zhu SY, Wang HL, Li M (2007) Efficacy of combined naloxone and aceglutamide treatment of hepatic encephalopathy: an clinical observation. Chinese Journal of Difficult and Complicated Cases, 6, 491.
14. Luo H, Gan XT, Nie QH (2003) Naloxone in the treatment of hepatic encephalopathy: 26 cases. Herald of Medicine, 22, 552.
15. Chen XD, Hong D (2005) Clinical observation of Naloxone in the treatment of hepatic encephalopathy. Chinese Journal of Celiopathy, 5, 201 202.
16. Gu YM, Gao YK (2007) Curative observation on hepatic cerebropathy treated with naloxone. Hei Long Jiang Medical Journal, 31, 213 214.
17. Huang CL (2005) Curative observation on hepatic cerebropathy treated with naloxone: 48 cases. Hei Long Jiang Medical Journal, 18, 222.
18. Li YQ, Chen ZF, Feng SG, Huang ZhQ (2005) The therapeutic effects of naloxone on 36 patients with subclinical hepatic encephalopathy. Medical Information, 18, 498 500.
19. Lin Y, Bi XF, Liu GB, Lin PY (2006) Curative observation on hepatic cerebropathy treated with naloxone. Hainan Medical Journal, 17, 140 141.
20. Liu JS, Fu Ji, Zhang XH, Wu YL (2004) Changes of plasma benzodiazepine and β- endorphin in hepatic encephalopathy patients and naloxone therapy. Journal of Postgraduates of Medicine (Medicine Edition), 27, 26 27.
21. Liu JT, Wang PZh, Gao F, Xue GQ (2000) Changes of plasma β- endorphin in hepatic encephalopathy patients and curative observation of naloxone therapy. Clinical Focus, 15, 747 748.
22. Pen HX, Wang HY (2002) Clinical studies on naloxone in the treatment of cirrhosis with hepatic encephalopathy. Central Plains Medical Journal, 29, 40 41.
23. Qian YD, Wang SP, Luo SX, Li MQ, Hu YCh (2005) Naloxone in the treatment of HB cirrhosis with hepatic encephalopathy: 27 cases. Chinese Journal of Integrated Traditional and Western Medicine on Liver Diseases, 15, 328.
24. Wang SW, Ping H, Tian WG, Yu H, Ding J (2006) Observation on therapeutic effects of Naloxone Hydrochloride Injection on 137 patients with hepatic encephalopathy. Chongqing Medicine, 35, 2070 2071.
25. Xiao HD (2005) Curative observation on cirrhosis with hepatic encephalopathy treated combined naloxone with arginine. Journal of Chinese Physician, 7, 709 710.
26. Xu WS, Liu YF, Wang YP, Li ZhD (2007) Curative observation on hepatic encephalopathy treated with naloxone. Chinese Journal of Clinical Hepatology, 23, 295 296.
27. Zhai SM, Wang ZhJ (2004) Curative observation on hepatic encephalopathy treated with naloxone. Chinese Community Doctors, 20, 26.
28. Zhu LC (2007) Naloxone in the treatment of cirrhosis with hepatic encephalopathy: an analysis of 48 cases. China Practical Medical, 2, 96 97.
29. Alderson P, Higgins JPT, Green S. Cochrane Reviewers' Handbook 5.0.1 [updated September 2008]. Available at: http://www.cochrane.org/resources/ handbook/hbook.htm.
30. Kjaergard LL, Villumsen J, Gluud C (2001) Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses. Annals of Internal Medicine, 135, 982 989.
31. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clinical Trials, 7, 177 188.
32. Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics, 50, 1088 1101.
33. Egger M, Smith GD, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629 634.
34. Snyder SH (1997) Opiate receptors in the brain. New England Journal of Medicine, 296, 266 271.
35. Kamel L, Saleh A, Morsy A, Ghali A, El Khayat H (2007) Plasma met-enkephalin, β-endorphin and leu-enkephalin levels in human hepatic encephalopathy. Eastern Mediterranean Health Journal, 13, 257 265.
36. Insinna F, Spinnato A (1987) A therapeutic proposal: naloxone for hepatic encephalopathy. Clinical Therapeutics, 10, 32 35.